Financials
- Market Capitalization 25.34 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
14.44
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 478 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 62.32 USD | +1.48% | +0.50% | +7.34% | +67.26% | 27.83 B USD | ||
| 493 | INSM Insmed Incorporated - Common Stock | 121.51 USD | -0.25% | -1.12% | +23.74% | -25.02% | 26.54 B USD | ||
| 509 | ROIV Roivant Sciences Ltd. - Common Shares | 34.52 USD | -0.35% | -6.53% | +4.04% | +88.53% | 24.93 B USD | ||
| 514 | BNTX BioNTech SE - American Depositary Shares | 101.95 USD | +0.33% | -9.71% | +12.02% | +1.24% | 24.47 B USD |